Advertisement

Topics

Base Pair Biotechnologies Completes $3.2 Million Series A-3 Financing Round and Opens New Facility

10:40 EST 28 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Accelerates growth in cell analysis, new technology and market development Base Pair Biotechnologies, Inc., The Aptamer Discovery Company™, today announced the completion of its $3.2 Million Series A-3 financing round ...

Other Sources for this Article

Media
Base Pair Biotechnologies
Vicki Singer, Ph.D., 832-230-5518
President & CEO
vicki.singer@basepairbio.com
or
Eventi Capital Partners
Scott Bryan, 416-927-8887
scott.bryan@eventi.com

NEXT ARTICLE

More From BioPortfolio on "Base Pair Biotechnologies Completes $3.2 Million Series A-3 Financing Round and Opens New Facility"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...